Quantifying the economic value and quality of life impact of earlier influenza vaccination

Medical Care

Volumn 53, Issue 3, 2015, Pages 218-229

  Lee, Bruce Y ^a   Bartsch, Sarah M ^a   Brown, Shawn T ^b   Cooley, Philip ^c   Wheaton, William D ^c   Zimmerman, Richard K ^d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c RTI INTERNATIONAL   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

economics; influenza; vaccination

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; ECONOMIC ASPECT; FEMALE; GROUPS BY AGE; HEALTH CARE; HEALTH CARE COST; HUMAN; IMMUNITY; INFANT; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PRODUCTIVITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SCHOOL CHILD; SEASON; UNITED STATES; COST BENEFIT ANALYSIS; DISEASE OUTBREAKS; ECONOMICS; EPIDEMIOLOGY; HEALTH STATUS; INFLUENZA, HUMAN; MASS IMMUNIZATION; PENNSYLVANIA; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA;

COST-BENEFIT ANALYSIS; DISEASE OUTBREAKS; FEMALE; HEALTH CARE COSTS; HEALTH STATUS; HUMANS; INFLUENZA, HUMAN; MALE; MASS VACCINATION; PENNSYLVANIA; PRIMARY HEALTH CARE; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SEASONS; UNITED STATES;

EID: 84924021230     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000000302     Document Type: Article

References (50)

1. Lee BY, Tai JH, Bailey RR, et al. The timing of influenza vaccination for older adults (65 years and older). Vaccine. 2009; 27:7110-7115.
2. Lee BY, Tai JH, Bailey RR, et al. Economics of influenza vaccine administration timing for children. Am J Manag Care. 2010; 16:e75-e85.
3. Lee BY, Shah M. Prevention of influenza in healthy children. Expert Rev Anti Infect Ther. 2012;10:1139-1152.
4. Centers for Disease Control and PreventionNational Influenza Vaccination Week Atlanta, GA2013. 2013. Available at: http://cdc.gov/flu/ nivw. Accessed April 15, 2013.
5. Centers for Disease Control and PreventionCDC-Seasonal Influenza (Flu) CDC2013. 2014. Available at: http://www.cdc.gov/flu/about/ season/flu-season.htm. Accessed November 4, 2014.
6. Cooley P, Lee BY, Brown ST, et al. Protecting health care workers: a pandemic simulation based on Allegheny County. Influenza Other Respir Viruses. 2010;4:61-72.
7. Lee BY, Brown ST, Cooley P, et al. Simulating school closure strategies to mitigate an influenza epidemic. J Public Health Manag Pract. 2010;16:252-261.
8. Lee BY, Brown ST, Cooley P, et al. Vaccination deep into a pandemic wave: potential mechanisms for a "third wave" and the impact of vaccination. Am J Prevent Med. 2010;39:e21-e29.
9. Lee BY, Brown ST, Korch GW, et al. A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic. Vaccine. 2010;28:4875-4879.
10. Grefenstette JJ, Brown ST, Rosenfeld R, et al. FRED (a Framework for Reconstructing Epidemic Dynamics): an open-source software system for modeling infectious diseases and control strategies using censusbased populations. BMC Public Health. 2013;13:940.
11. Ferguson NM, Cummings DAT, Fraser C, et al. Strategies for mitigating an influenza pandemic. Nature. 2006;442:448-452.
12. Halloran ME, Ferguson NM, Eubank S, et al. Modeling targeting layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci USA. 2008;105:4639-4644.
13. Longini IMJ, Nizam A, Xu S, et al. Containing pandemic influenza at the source. Science. 2005;309:1083-1087.
14. Beigi RH, Wiringa AE, Bailey RR, et al. Economic value of seasonal and pandemic influenza vaccination during pregnancy. Clin Infect Dis. 2009;49:1784-1792.
15. Lee BY, Bacon KM, Donohue JM, et al. From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination. Vaccine. 2011;29:2149-2158.
16. Lee BY, Bailey RR, Wiringa AE, et al. Economics of employersponsored workplace vaccination to prevent pandemic and seasonal influenza. Vaccine. 2010;28:5952-5959.
17. Lee BY, Bartsch SM, Willig AM. The economic value of a quadrivalent versus trivalent influenza vaccine. Vaccine. 2012; 30:7443-7446.
18. Lee BY, Stalter RM, Bacon KM, et al. Cost-effectiveness of adjuvanted versus nonadjuvanted influenza vaccine in adult hemodialysis patients. Am J Kidney Dis. 2011;57:724-732.
19. Lee BY, Tai JHY, McGlone SM, et al. The potential economic value of a "universal" (multi-year) influenza vaccine. Influenza Other Respir Viruses. 2012;6:167-175.
20. Bureau of Labor Statistics. Occupational Employment Statistics: May 2012 National Occupational Employment and Wage Estimates. Washington, DC: US Bureau of Labor Statistics Division of Occupational Employment Statistics; 2012. Available at: http://www.bls.gov. Accessed September 4, 2013.
21. Human Mortality Database [Internet]. University of California, Berkeley (USA), and Max Planck Institute for Demographic Reseach (Germany). 2010. Available at: http://www.mortality.org. Accessed June 14, 2011.
22. Guide to Community Preventive ServicesIncreasing approriate vaccination. 2014. Available at: http://www.thecommunityguide.org/vaccines/ index.html. Accessed June 12, 2014.
23. Skowronski DM, Tweed SA, De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?. J Infect Dis. 2008;197:490-502.
24. Song JY, Cheong HJ, Hwang IS, et al. Long-term immunogenicity of influenza vaccine among the elderly: risk factors for poor immune response and persistence. Vaccine. 2010;28:3929-3935.
25. Ambrose CS, Yi T, Walker RE, et al. Duration of protection provided by live attenuated influenza vaccine in children. Pediatr Infect Dis J. 2008;27:744-748.
26. Ohmit SE, Thompson MG, Petrie JG, et al. Infulenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014;58:319-327.
27. Lee BY. Digital decision making: computer models and antibiotic prescribing in the twenty-first century. Clin Infect Dis. 2008;46: 1139-1141.
28. Osterholm MT, Kelley NS, Sommer A, et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:36-44.
29. Centers for Disease Control and PreventionCDC Vaccine Price List Atlanta, GA: US Department of Health and Human Services. 2013. Available at: http://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/2013/2013-04-16.html. Accessed April 20, 2013.
30. Thomson HealthcareMarketScan Research Database Ann Arbor, MI. 2008.
31. Centers for Medicare & Medicaid Services. Physicians Fee Schedule. Baltimore, MD: US Department of Health & Human Services; 2009. Available at: http://www.cms.hhs.gov/. Accessed March 16, 2011.
32. United States Department of Health & Human Services. HCUP Facts and Figures: Statistics on Hospital-based Care in the United States. Rockville, MD: AHRQ: Agency for Healthcare Research and Quality; 2010. Available at: http://www.hcup-us.ahrq.gov/reports.jsp. Accessed April 23, 2013.
33. Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008;167:775-785.
34. Palmer LA, Rousculp MD, Johnston SS, et al. Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: the child and household influenza-illness and employee function (CHIEF) study. Vaccine. 2010;28:5049-5056.
35. Nettleman MD, While T, Lavoie S, et al. School absenteeism, parental work loss, and acceptance of childhood influenza vaccination. Am J Med Sci. 2001;321:178-180.
36. Molinari N-AM, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25:5086-5096.
37. Kreech M, Beardsworth P. The impact of influenza on working days lost. A review of the literature. Pharmacoeconomics. 2008;26: 911-924.
38. Bridges C, Katz JM, Levandowski RA, et al. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 5th ed. Philadelphia, PA: Elsevier; 2008:257-290.
39. Gold MR, Franks P, McCoy KI, et al. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care. 1998;36:778-792.
40. Smith KJ, Lee BY, Nowalk MP, et al. Cost-effectiveness of dual influenza and pneumococcal vaccination in 50-year-olds. Vaccine. 2010;28:7620-7625.
41. Smith KJ, Roberts MS. Cost-effectiveness of newer treatment strategies for influenza. Am J Med. 2002;113:300-307.
42. Rothberg MB, Rose DN. Vaccination versus treatment of influenza in working adults: a cost-effective analysis. Am J Med. 2005; 118:68-77.
43. Khazeni N, Hutton DW, Garber AM, et al. Effectiveness and costeffectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med. 2009;151:829-839.
44. Talbird SE, Brogan AJ, Winiarski AP, et al. Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States. Am J Health System Pharm. 2009;66:469-480.
45. Luce BR, Nichol KL, Belshe RB, et al. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children ages 24-59 months in the United States. Vaccine. 2008;26:2841-2848.
46. Perlroth DJ, Glass RJ, Davey VJ, et al. Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States. Clin Infect Dis. 2010;50:165-174.
47. Michaelidis CI, Zimmerman RK, Nowalk MP, et al. Estimating the costeffectiveness of a national program to eliminate disparities in influenza vaccination rates among elderly minority groups. Vaccine. 2011;29: 3525-3530.
48. Mauskopf JA, Cates SC, Griffin AD, et al. Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in Australia. Pharmacoeconomics. 2000;17:611-620.
49. Lee BY, Tai JHY, Bailey RR, et al. Economics of influenza vaccine administration timing for children. Am J Manag Care. 2010;16:e75-e85.
50. Jit M, Cromer D, Baguelin M, et al. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales. Vaccine. 2010;29:115-122.